IONS   $39.68  3.09% Market Closed After Close 39.5 -0.45%

Ionis Pharmaceuticals Inc
Total Cash 2.09B
totalCashPerShare 14.264
EBITDA -330.68M
Total Debt 1.99B
quickRatio 6.901
currentRatio 7.608
Total Revenue 813.46M
debtToEquity 753.054
Revenue/Share 5.625
ROA -0.07579
ROE -1.05706
grossProfits
freeCashflow -211.82M
operatingCashflow -345.98M
earningsGrowth
revenueGrowth 0.196
grossMargins -0.1286
ebitdaMargins -0.4065
operatingMargins -0.29341
profitMargins -0.44961
enterpriseValue 5.43B
forwardPE -10.60137
floatShares 145.04M
sharesOutstanding 157.71M
sharesShort 10.53M
sharesShortPriorMonth 10.16M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.96%
Short Ratio help_outline 4.41%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 1.806
Price To Book help_outline 21.43
earningsQuarterlyGrowth
netIncomeToCommon -365.74M
trailingEps -2.52%
forwardEps -3.65%
enterpriseToEbitda -16.43
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.15 3Q 2024
institutionsCount 504
lastUpdated Oct. 16, 2024, 6:42 p.m.